Christopher deFilippi Selected Research

omega-Chloroacetophenone (Mace)

5/2015

Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher deFilippi Research Topics

Disease

17	Heart Failure 05/2022 - 01/2013
10	Myocardial Infarction 05/2022 - 07/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 12/2020 - 01/2013
6	Chronic Renal Insufficiency 11/2019 - 05/2009
5	Inflammation (Inflammations) 05/2022 - 09/2014
5	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 05/2009
3	Fibrosis (Cirrhosis) 05/2022 - 01/2018
3	Chest Pain (Chest Pains) 01/2020 - 05/2015
3	Coronary Artery Disease (Coronary Atherosclerosis) 05/2015 - 07/2003
2	Unstable Angina 10/2020 - 05/2015
2	Dyspnea (Shortness of Breath) 01/2020 - 04/2015
2	Atherosclerosis 12/2019 - 10/2017
2	Hypertension (High Blood Pressure) 12/2019 - 05/2015
2	Left Ventricular Dysfunction 02/2013 - 01/2013
2	Acute Coronary Syndrome 09/2012 - 07/2003
1	Arteritis 11/2022
1	ST Elevation Myocardial Infarction 05/2022
1	Shock 05/2022
1	Thrombosis (Thrombus) 05/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Anemia 11/2021
1	COVID-19 01/2021
1	Ventricular Tachycardia 12/2020
1	Stroke (Strokes) 10/2020
1	Proteinuria 11/2019
1	Venous Thromboembolism 10/2017
1	Atrial Fibrillation 05/2015
1	Ventricular Remodeling 04/2015
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 12/2013
1	Hypertrophy 02/2013
1	Coronary Disease (Coronary Heart Disease) 09/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2003
1	Cardiomyopathies (Cardiomyopathy) 07/2003

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2013
9	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2013
8	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 02/2013
8	TroponinIBA 01/2020 - 09/2012
7	Troponin T (Troponin T1)IBA 12/2020 - 07/2003
5	Troponin IIBA 01/2021 - 09/2012
3	Growth Differentiation Factor 15IBA 05/2022 - 01/2018
3	Galectin 3 (LGALS3)IBA 12/2020 - 06/2014
2	CholesterolIBA 05/2022 - 11/2019
2	MineralsIBA 05/2022 - 11/2019
2	trans-crotonin (CTN)IBA 10/2020 - 01/2020
2	C-Reactive ProteinIBA 09/2014 - 07/2003
2	Fibroblast Growth Factor-23IBA 01/2013 - 05/2009
1	Biological ProductsIBA 11/2022
1	AldosteroneIBA 11/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 11/2022
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 05/2022
1	Trefoil Factor-3IBA 05/2022
1	Tartrate-Resistant Acid PhosphataseIBA 05/2022
1	CollagenIBA 05/2022
1	Interleukin-1 (Interleukin 1)IBA 05/2022
1	LDL Receptors (LDL Receptor)IBA 05/2022
1	Protein Tyrosine PhosphatasesIBA 05/2022
1	Galectin 4 (LGALS4)IBA 05/2022
1	Metalloproteases (Metalloproteinases)IBA 05/2022
1	OsteoprotegerinIBA 05/2022
1	Cathepsin ZIBA 05/2022
1	Torsemide (Demadex)FDA LinkGeneric 03/2022
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 03/2022
1	Proteins (Proteins, Gene)FDA Link 03/2022
1	Furosemide (Lasix)FDA LinkGeneric 03/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	vericiguatIBA 11/2021
1	Flecainide (Tambocor)FDA LinkGeneric 12/2020
1	sacubitrilIBA 01/2020
1	Neprilysin (Neutral Endopeptidase)IBA 01/2020
1	CalciumIBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Valsartan (Vals)FDA Link 01/2020
1	Natriuretic PeptidesIBA 01/2020
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 12/2019
1	Trinitrotoluene (TNT)IBA 08/2019
1	Lipopolysaccharide ReceptorsIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	vinyltriethoxysilane (VTES)IBA 10/2017
1	omega-Chloroacetophenone (Mace)IBA 05/2015
1	proadrenomedullinIBA 05/2015
1	Eplerenone (Inspra)FDA LinkGeneric 04/2015

Therapy/Procedure

3	Therapeutics 05/2022 - 01/2018
1	Percutaneous Coronary Intervention 05/2022
1	Patient Readmission 06/2014
1	Renal Dialysis (Hemodialysis) 07/2003